Johnson & Johnson (JNJ) Tops Q1 EPS by 2c; Raises FY12 EPS Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $275.23 --0%
Revenue Growth %: +5.5%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.5%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $1.37, $0.02 better than the analyst estimate of $1.35. Revenue for the quarter came in at $16.1 billion versus the consensus estimate of $16.26 billion.
Sees FY2012 EPS of $5.07-$5.17, versus prior guidance of $5.05-$5.15 and the consensus of $5.11.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Sees FY2012 EPS of $5.07-$5.17, versus prior guidance of $5.05-$5.15 and the consensus of $5.11.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Morgan Stanley Upgrades M&T Bank (MTB) to Overweight
- Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
Create E-mail Alert Related Categories
Earnings, Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
